Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
39.00
+0.59 (1.54%)
At close: Aug 10, 2026, 4:00 PM EDT
39.18
+0.18 (0.46%)
After-hours: Aug 10, 2026, 5:16 PM EDT
HRMY Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, HRMY stock has a consensus rating of "Buy" and an average price target of $46.1. The average 1-year stock price forecast is 18.21% higher than the current stock price, while the lowest is $30 (-23.08%) and the highest is $70 (+79.49%).
Price Target: $46.1 (+18.21%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HRMY stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 4 | 4 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Hold Maintains $29 → $34 | Hold | Maintains | $29 → $34 | -12.82% | Aug 5, 2026 |
| Deutsche Bank | Deutsche Bank | Hold Reiterates $36 → $39 | Hold | Reiterates | $36 → $39 | n/a | Aug 5, 2026 |
So Youn Shim UBS No rating | UBS | Hold Maintains $33 → $37 | Hold | Maintains | $33 → $37 | -5.13% | Aug 5, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Reiterates $28 → $30 | Sell | Reiterates | $28 → $30 | -23.08% | Aug 5, 2026 |
| Needham | Needham | Buy Maintains $45 → $50 | Buy | Maintains | $45 → $50 | +28.21% | Aug 4, 2026 |
Financial Forecast
Revenue This Year
1.03B
from 868.45M
Increased by 19.05%
Revenue Next Year
1.17B
from 1.03B
Increased by 12.97%
EPS This Year
5.22
from 3.60
Increased by 45.05%
EPS Next Year
6.69
from 5.22
Increased by 28.05%
EPS and Forward PE are based on non-GAAP adjusted numbers.